Wuhan Corona Virus (COVID19) is a legitimate health concern, but it is no cause for panic or irrational hysteria.

It is not the 21st Century equivalent of the Black Death.’

At least not in our country, we have state of the art medicine and hospitals as well as a team of doctors that are well trained.

But in third world countries, it could be totally different.

Especially in the middle-east where Muslim leaders call for their followers to rely solely on God for the treatment of diseases.

As the New Arab reported Iraqi cleric Muqtada al-Sadr has been mocked online after tweeting he would not accept any coronavirus cure made by the “infidel” United States, as the outbreak’s death toll continues to mount.

The influential Shia leader posted on Wednesday addressing US President Trump, blaming him for the spread of the disease and accusing the US of having the most coronavirus cases.

“Trump, you have filled the world with wars, occupations, and poverty, and now you claim that you are the healer. But this disease is spreading because of your awful policies,” his statement said.

He said that he does not want any medicine from Trump because he is an “infidel”, adding that he and his supporters rely solely on God for the treatment of diseases.

Social media users slammed the tweet, accusing Sadr of hypocrisy, as US-made drugs are widely used in Iraq.

Others called on Sadr to cooperate with the rest of the world in order to tackle the coronavirus pandemic, which risks turning into a humanitarian crisis if it spreads widely in Iraq.

Well, maybe he will refuse to take the vaccine that is on its way as US scientists confirmed that they have completed a Coronavirus vaccine.

As the Daily Mail reported:

Scientists at Greffex, a Houston, Texas-based genetic engineering company, claim they’ve created a coronavirus vaccine.

The company told the Houston Business Journal that it had completed development of the vaccine and it is ready for animal testing and review by US regulators.

Developing a vaccine, however, is just the first step toward distributing one. Most estimates suggest that from, testing and production could take between 18 months and two years, though Greffex has not announced its timeline.

Greffex’s vaccine comes after the National Institutes of Health (NIH) gave the company a grant of up to $18.9 million to develop a ‘plug-and-play’ platform that would let it add a few specific ingredients, so to speak, to it’s basic formula and quickly design vaccines.

Now that the candidate vaccine is read, they’ll have to test it in animals, then begin phase 1 clinical trials in people, followed by another two phases of human trials, and ultimately Food and Drug Administration (FDA) approval.

Vaccines can take upwards of a decade to develop, from soup to nuts.

Even with all the expediting possible, testing required by the FDA is thorough and time-consuming, so fast production of a vaccine will still like to take 18 months to a year.

But if things get more serious they will need to speed up the process.

Scientists at the University of Texas, Austin, had to recreate a molecule that makes up the spike protein on the surface of the coronavirus (now know as SARS-CoV-2) in order to create a three-dimensional map of the structure.

And the compound they made to do so itself can work as a vaccine, triggering an immune response to the virus, they believe.

Like the UT Austin team and their collaborators at Moderna Therapeutics, the Greffex team believe that their process for production is among the fastest available to produce a vaccine.

‘The trick in making a vaccine is can you scale the vaccine that you’ve made to be able to make a certain number of doses, can you test the vaccine quickly and efficiently and then can you get it into patients – and that’s where we have an edge as well on the other companies that are out there,’ Greffex CEO John Price told

KHOU.